Cell-Based Assays Market estimated worth 18,329.37 Million USD by 2020 - PowerPoint PPT Presentation

Loading...

PPT – Cell-Based Assays Market estimated worth 18,329.37 Million USD by 2020 PowerPoint presentation | free to download - id: 86f7fa-MjJiN



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Cell-Based Assays Market estimated worth 18,329.37 Million USD by 2020

Description:

The global cell-based assays market is expected to reach USD 18,329.37 Million by 2020 from USD 10,799.53 Million in 2015, growing at a CAGR of 11.16% between 2015 and 2020. – PowerPoint PPT presentation

Number of Views:12

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Cell-Based Assays Market estimated worth 18,329.37 Million USD by 2020


1
MarketsandMarkets Presents
Cell-based Assays Market- India and China to
offer significant growth opportunities
http//www.marketsandmarkets.com/Market-Reports/ce
ll-based-assays-market-119917269.html
2
The report Cell-based Assays Market by Product
(Cell Lines, Reagents, Kits, Instruments,
Software, Services), Applications (Research, Drug
Discovery, ADME Studies, Toxicology), End User
(Pharmaceutical Companies, Academics, CRO),
Region - Global Forecast to 2020 The report
provides a detailed overview of the major
drivers, restraints, opportunities and trends
impacting the global cell-based assays market
along with the estimates and forecasts of the
revenue and market share analysis. Browse 74
market data tables 87 figures 169 pages and
in-depth TOC on "Cell-based Assays
Market Download The PDF Brochure_at_ http//www.mar
ketsandmarkets.com/pdfdownload.asp?id119917269 T
he global cell-based assays market is expected to
reach USD 18,329.37 Million by 2020 from USD
10,799.53 Million in 2015, growing at a CAGR of
11.16 between 2015 and 2020.
http//www.marketsandmarkets.com/Market-Reports/ce
ll-based-assays-market-119917269.html
3
Based on products the cell-based assays market is
segmented into consumables, instruments, services
and software. Consumables are further classified
as reagents and assay kits, cell lines, micro
plates. Cell-based assays have a broad range of
applications in basic research, drug discovery
and ADME studies. Speak to Analyst_at_ http//www.m
arketsandmarkets.com/speaktoanalyst.asp?id1199172
69 It have vital role in the pharmaceutical and
biotechnology companies, academic institutions,
and CROs for these applications. The major driver
for this market is the widespread use of
cell-based assays in drug discovery processes.
Based on geography the global market is segmented
into North America, Europe, Asia and Rest of the
World (RoW).
http//www.marketsandmarkets.com/Market-Reports/ce
ll-based-assays-market-119917269.html
4
However, high cost of instruments and
intellectual property issues are the major
factors restraining the growth of this market.
Asian region offers large opportunities in this
market due to growing RD spending. Emerging
economies are making huge investments in RD as
opportunities in basic research and drug
discovery are big and growing very rapidly. It is
the fastest growing area of the industry. The
demand for life science products in emerging
Asian nations such as China and India is growing
at a robust rate compared to developed countries.
The Asian markets, especially China and India,
have a large number of CROs that offer drug
discovery services to serve pharmaceutical and
biotechnology companies which ultimately drives
cell-based assays market.
http//www.marketsandmarkets.com/Market-Reports/ce
ll-based-assays-market-119917269.html
5
The top leaders in cell-based assays market
include Becton, Dickinson and Company (U.S.),
Merck Co, Inc. (U.S.), Danaher Corporation
(U.S.), Thermo Fisher Scientific, Inc. (U.S.),
PerkinElmer, Inc. (U.S.), Cell Signaling
Technology, Inc. (U.S.), Cisbio Bioassays
(France), DiscoveRx (U.S.), General Electric
Company (U.S.), and Promega Corporation (U.S.).
http//www.marketsandmarkets.com/Market-Reports/ce
ll-based-assays-market-119917269.html
6
About MarketsandMarkets MarketsandMarkets
provides quantified B2B research on 30,000 high
growth niche opportunities/threats which will
impact 70 to 80 of worldwide companies
revenues. Currently servicing 5000 customers
worldwide including 80 of global Fortune 1000
companies as clients. Almost 75,000 top officers
across eight industries worldwide approach
MarketsandMarkets for their painpoints around
revenues decisions.   Our 850 fulltime analyst
and SMEs at MarketsandMarkets are tracking
global high growth markets following the "Growth
Engagement Model GEM". The GEM aims at
proactive collaboration with the clients to
identify new opportunities, identify most
important customers, write "Attack, avoid and
defend" strategies, identify sources of
incremental revenues for both the company and its
competitors. MarketsandMarkets now coming up
with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies,
innovators, strategic players) annually in high
growth emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve.   MarketsandMarketss flagship
competitive intelligence and market research
platform, "RT" connects over 200,000 markets and
entire value chains for deeper understanding of
the unmet insights along with market sizing and
forecasts of niche markets.   
http//www.marketsandmarkets.com/Market-Reports/ce
ll-based-assays-market-119917269.html
7
Contact Us
Mr. Rohan MarketsandMarkets 701 Pike Street
Suite 2175, Seattle, WA 98101, United States
Tel 1-888-600-6441 Email sales_at_marketsandmarket
s.com MarketsandMarkets Bloghttp//www.marketsan
dmarkets.comhttp//twitter.com/marketsmarkets htt
p//www.linkedin.com/company/marketsandmarkets
About PowerShow.com